Sunshine Biopharma, Inc. (SBFMW) NASDAQ
0.09
+2.9999999984209325e-9(+0.00%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.09
+2.9999999984209325e-9(+0.00%)
Currency In USD
| Market Cap | 2.11M |
| Enterprise Value | -6.63M |
| P/E Ratio | -0.81 |
| PEG Ratio | -0.11 |
| Price/Sales Ratio | 0.14 |
| Price/Book Ratio | 0.2 |
| Enterprise/Revenue | -0.09 |
| Enterprise/EBITDA | 0.54 |
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | September 30, 2025 |
| Profit Margin | -0.16 |
| Operating Margin | -0.17 |
| Return On Assets | -0.19 |
| Return On Equity | -0.25 |
| Revenue | 34.87M |
| Revenue/Share | 8.02 |
| Gross Profit | 10.67M |
| EBITDA | -5.15M |
| Net Income | -5.13M |
| Diluted EPS | -7.32 |
| Total Cash | 9.31M |
| Total Cash/Share | 2 |
| Total Debt | 854,761 |
| Total Debt/Equity | 0.04 |
| Current Ratio | 4.2 |
| Book Value Per Share | 5.2 |
| 52-Week Change | -65.89 |
| 52-Week High | 0.3 |
| 52-Week Low | 0.09 |
| Moving Average 50 Days | 0.15 |
| Moving Average 200 Days | 0.21 |
| Average Volume | 3,293.17 |
| Shares Outstanding | 4.91M |
| % Held by Institutions | 0.5 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |